Coming at BIO 2011
Starting Up Biotechs in the New Normal World
Wednesday, June 15, 2011
Private biotechs raised just $1.76 billion through May 2011 putting this year on pace to come in below the $4.48 billion raised last year and even the $4.13 billion raised in 2008. But Seed and Series A funding at 27.5 percent accounted for more of the pie than usual . . . if you count a couple of hefty non-VC rounds.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.